1. Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators.
- Author
-
Cho RJ, McCalmont TH, Ai WZ, Fox LP, Treseler P, and Pincus LB
- Subjects
- Adult, B-Lymphocytes metabolism, B-Lymphocytes pathology, Biopsy, Diagnosis, Differential, Humans, Immunohistochemistry methods, Reed-Sternberg Cells metabolism, Reed-Sternberg Cells pathology, Biomarkers, Tumor metabolism, Hodgkin Disease metabolism, Hodgkin Disease pathology, Octamer Transcription Factor-2 metabolism, PAX5 Transcription Factor metabolism, Skin Neoplasms metabolism, Skin Neoplasms pathology, Trans-Activators metabolism
- Abstract
In lymph nodes, classical Hodgkin lymphoma can typically be distinguished from non-Hodgkin lymphoma (NHL) by the presence of Hodgkin and Reed-Sternberg cells that co-express CD30 and CD15. However, anaplastic large cell lymphoma (ALCL) and diffuse large B-cell lymphoma (DLBCL) can show identical features, and some cases of classical Hodgkin lymphoma lack CD15 expression, rendering them difficult to differentiate from CD30-positive NHL. The differential diagnosis of cutaneous Hodgkin lymphoma similarly includes ALCL and DLBCL, and, additionally, tumors of mycosis fungoides. Recent studies have shown that classical Hodgkin lymphoma is of B-cell origin in virtually all cases, and shows at least focal weak expression of the B-cell marker PAX5 and often focal weak expression and no expression of the B-cell markers Oct-2 and BOB.1, respectively. All three of these markers are almost invariably absent in T-cell lymphomas and are strongly expressed in B-cell lymphomas. We report a 40-year-old man with classical Hodgkin lymphoma who developed cutaneous nodules. A biopsy from one revealed Hodgkin/Reed-Sternberg cells with a similar immunophenotype to the diagnostic lymph node biopsy, namely CD30+/CD15+, diffusely but weakly PAX5+, focally weakly Oct-2+ and lacking BOB.1 expression, thereby confirming a diagnosis of cutaneous Hodgkin lymphoma. To our knowledge, this is the first report of the expression pattern of the combination of PAX5, Oct-2 and BOB.1 in the context of cutaneous involvement by Hodgkin lymphoma., (Copyright © 2012 John Wiley & Sons A/S.)
- Published
- 2012
- Full Text
- View/download PDF